mRNA-4157,Pembrolizumab
Moderna,Merck
['key,note,42', 'mrna-4157', 'key,note,57', 'keynote,942', 'melanoma', 'pembro', 'moderna']
keynote 942 ph2 study in resected high risk melanoma pts showed a better outcome for those pts treated with the combo mrna-4157+pembro vs pembro alone: ho 0.561 p 0.0266. let s go to the ph3. a new era for melanoma pts #jeffweber #aacr2023 
Ricercatore Oncologo presso Istituto Nazionale Tumori Fondazione Pascale di Napoli._x000D_
Medical oncologist from National Cancer Institute of Naples, Italy